• Fulfilling the Promise of Personalized Medicine. Caris Life Sciences was founded because of an idea — that personalized and precise information can improve healthcare for everyone. This idea drives everything we do at Caris Life Sciences. Caris combines the rigor of an academic medical institution with the innovative spirit of a technology company. We believe that innovative, high-quality testing and information can lead to more effective treatment selection and ultimately to better outcomes for patients with cancer and other complex diseases. 

  • Genetic testing for hereditary and somatic cancers can provide life-changing results in affected patients and their relatives, accompanied by potential actionable steps for genetic-related cancers.



  • MDxHealth is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of our ConfirmMDx® for Prostate Cancer testing solution within the U.S. urology community has established MDxHealth as a market leader in the important and growing field of cancer epigenetics.



  • Inivata is a leader in liquid biopsy. InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients.